GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (NAS:CYCCP.PFD) » Definitions » Beginning Cash Position

CYCCP.PFD (Cyclacel Pharmaceuticals) Beginning Cash Position : $6.00 Mil (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Cyclacel Pharmaceuticals Beginning Cash Position?

Cyclacel Pharmaceuticals's Beginning Cash Position for the quarter that ended in Sep. 2024 was $6.00 Mil.

Cyclacel Pharmaceuticals's quarterly Beginning Cash Position declined from Mar. 2024 ($3.38 Mil) to Jun. 2024 ($2.80 Mil) but then increased from Jun. 2024 ($2.80 Mil) to Sep. 2024 ($6.00 Mil).

Cyclacel Pharmaceuticals's annual Beginning Cash Position increased from Dec. 2021 ($33.41 Mil) to Dec. 2022 ($36.56 Mil) but then declined from Dec. 2022 ($36.56 Mil) to Dec. 2023 ($18.35 Mil).

Cyclacel Pharmaceuticals Beginning Cash Position Historical Data

The historical data trend for Cyclacel Pharmaceuticals's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclacel Pharmaceuticals Beginning Cash Position Chart

Cyclacel Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.50 11.89 33.41 36.56 18.35

Cyclacel Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.16 5.94 3.38 2.80 6.00

Cyclacel Pharmaceuticals Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Cyclacel Pharmaceuticals Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Cyclacel Pharmaceuticals's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyclacel Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (NAS:CYCCP.PFD) » Definitions » Beginning Cash Position
Comparable Companies
MTEM QRON HALB DRMA ENTO GRTX SXTP BTAX SONN SLRX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
CYCC:USA UXI:Germany
Address
200 Connell Drive, Suite 1500, Berkeley Heights, NJ, USA, 07922
Website
https://cyclacel.com
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.